Cafepharma Today

Memorial Day Weekend 2025
We wish all our US visitors a safe and enjoyable holiday weekend. We remember those who have given their lives to defend and protect our country.

CP Today will resume on Tuesday, May 27

*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Germany's Merck looks for deals to lift U.S. drug sales
Yahoo/Reuters
Tuesday, November 26, 2013 - 9:37am
tags:
Merck KGaA, EMD Serono, M&A
2 Biotech Stocks Rising on Big Volume
TheStreet.com
Tuesday, November 26, 2013 - 9:02am
tags:
Anika, Enanta
Milestone payment triggers Genmab guidance increase
Yahoo/Reuters
Tuesday, November 26, 2013 - 9:00am
tags:
Genmab, daratumumab, JNJ, Janssen
Smith & Nephew to buy Brazilian wound care distribution
Reuters
Tuesday, November 26, 2013 - 8:58am
tags:
wound care, devices, M&A, Brazil, Smith & Nephew, Politec Saude
Sanofi looking at 1-2 billion euros in acquisitions per year - CEO
Reuters
Tuesday, November 26, 2013 - 8:56am
tags:
Sanofi, M&A, Pharma CEOs, Chris Viehbacher
Parental Attitudes on Sex, Costs Stymie HPV Vaccinations
Bloomberg
Tuesday, November 26, 2013 - 8:55am
tags:
HPV, vaccines, Cervarix, GSK, Merck, Gardasil
A Look At Abbott's Vascular Division
Seeking Alpha
Tuesday, November 26, 2013 - 8:54am
tags:
Abbott Laboratories, vascular
Merrimack, Actavis announce nanotechnology collaboration
Yahoo/Fly on the Wall
Tuesday, November 26, 2013 - 8:52am
tags:
Merrimack, Actavis, Nanotechnoogy
Apricus Biosciences expects to announce additional Vitaros partnerships
The Fly on the Wall
Tuesday, November 26, 2013 - 8:52am
tags:
Apricus Biosciences, Vitaros
Biotech IPOs Are Back To Normal
Seeking Alpha
Tuesday, November 26, 2013 - 8:51am
tags:
biotech, IPOs, Agios Pharmaceuticals, Omthera, Relypsa
MannKind: A Breakout Biotechnology Bet
Seeking Alpha
Tuesday, November 26, 2013 - 8:49am
tags:
MannKind, Afrezza, diabetes
Bayer bids $2.4 billion for Norwegian cancer drug partner Algeta
Yahoo/Reuters
Tuesday, November 26, 2013 - 8:48am
tags:
Bayer, M&A, Algeta
What Copaxone Profits? Yet Another Troubling Leak At Teva
Pharmalot
Monday, November 25, 2013 - 6:23pm
tags:
Teva, Copaxone, MS, multiple sclerosis
FDA overturns safety restrictions on diabetes pill Avandia based on new heart safety data
Yahoo/AP
Monday, November 25, 2013 - 6:17pm
tags:
FDA, Avandia, GSK, diabetes
Pfizer: 3 Different Insiders Have Sold Shares During The Last 30 Days
Seeking Alpha
Monday, November 25, 2013 - 6:16pm
tags:
Pfizer
ImmunoCellular Therapeutics Soars on Positive Brain Cancer Data
Wall St Cheat Sheet
Monday, November 25, 2013 - 5:30pm
tags:
ImmunoCellular Therapeutics, glioblastoma multiforme, brain cancer, ICT-107
[video] A Chart You Should See: Investors Put Greater Weight Behind Orexigen Than Arena, Vivus
TheStreet.com
Monday, November 25, 2013 - 12:54pm
tags:
Orexigen, obesity, Contrave, Vivus, Arena Pharmaceuticals
Portola shoots for early FDA approval after nabbing 'breakthrough' status
Fierce Biotech
Monday, November 25, 2013 - 11:57am
tags:
FDA, Portola, breakthrough therapies, andexanet alfa, bloodthinners
Cubist says urinary tract infection drug succeeds in study
Yahoo/Reuters
Monday, November 25, 2013 - 11:50am
tags:
Cubist Pharmaceuticals, urinary tract infection, CXA-201
Orexigen rises after obesity drug doesn't increase heart risk in study
The Fly on the Wall
Monday, November 25, 2013 - 11:45am
tags:
Orexigen, obesity, Contrave

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.